St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
- Fundraising
Seth Karol, MD
Associate Member, St. Jude Faculty
On this page:
Contact Information
Seth Karol, MD
Leukemia/Lymphoma
MS 260, Room C6064
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Education
BS – Duke University, Durham, North Carolina
MD – The Ohio State University, Columbus, Ohio
Research Interests
- Reducing the side effects of therapy in children with acute lymphoblastic leukemia (ALL)
- Identifying new treatments for children with leukemia after relapse
Clinical Trials
Recruiting
Study goal:
To find out whether a child’s leukemia or lymphoma is low-risk, standard-risk, or high-risk. The risk category will determine the treatment the child will receive.
Recruiting
Study goal:
To compare the effects of adding venetoclax, dasatinib, or bortezomib to standard chemotherapy for T-ALL, T-LLy, and MPAL, and to learn more about the biological and genetic or genomic traits that predict treatment success and toxicity in children.
Recruiting
Study goal:
To compare the effects of adding inotuzumab and blinatumomab to standard chemotherapy during treatment for newly diagnosed ALL and LLy; to learn whether the length of time that inotuzumab stays in the body affects treatment success or side effects; to learn more about the biological and genetic or genomic traits that predict treatment success and toxicity in children.
